Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Silo Pharma, Inc. (SILO)

Silo Pharma buys software and IP from Larry King for 150,000 shares

Neutral Impact 2 of 5 m&a Written later

Silo Pharma signed an asset purchase agreement on October 13, 2026, to acquire certain software and related intellectual property from Larry King. The company paid by issuing 150,000 shares of common stock, which are locked up for up to 12 months. The filing does not state the value of the assets or the share price, so the deal's size relative to Silo's business cannot be assessed from this filing.

Key points

  • Agreement dated October 13, 2026, with Larry King as seller
  • Consideration: 150,000 shares of common stock, par value $0.0001 per share
  • Shares locked up until the earliest of 12 months, a Change in Control, or company consent
  • Seller indemnifies the company for misrepresentation, third-party infringement and gross negligence, fraud or intentional misconduct

The filing

CompanySilo Pharma, Inc. (SILO)
Form8-K, current report
Filed with the SECOct 14, 2026, 4:30 PM ET
Accession number0001213900-26-109457

Items reported: 1.01 Material Definitive Agreement3.02 Unregistered Equity Sale

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.